Table 2 Relationship between GLR levels and mortality at 30 days and 365 days in a Cox regression model.

From: Association between glucose-to-lymphocyte ratio and mortality in patients with heart failure from the MIMIC-IV database: a retrospective cohort study

GLR

Model1

Model2

Model3

Model4

HR (95%CI)

P

HR (95%CI)

P

HR (95%CI)

P

HR (95%CI)

P

30-day mortality

        

Continuous variable

1.01 (1.01, 1.01)

< 0.001

1.01 (1.01, 1.01)

< 0.001

1.01 (1.01, 1.01)

0.005

1.01 (1.01, 1.01)

0.031

Categorical variable

        

≤ 143.35

1.00 (Reference)

 

1.00 (Reference)

 

1.00 (Reference)

 

1.00 (Reference)

 

> 143.35

1.78 (1.66, 1.92)

< 0.001

1.58 (1.47, 1.71)

< 0.001

1.47 (1.36, 1.59)

< 0.001

1.37 (1.26, 1.48)

< 0.001

365-day mortality

        

Continuous variable

1.01 (1.01, 1.01)

< 0.001

1.01 (1.01, 1.01)

< 0.001

1.01 (1.01, 1.01)

< 0.001

1.01 (1.01, 1.01)

< 0.001

Categorical variable

        

≤ 143.35

1.00 (Reference)

 

1.00 (Reference)

 

1.00 (Reference)

 

1.00 (Reference)

 

> 143.35

1.70 (1.61,1.79)

< 0.001

1.57 (1.49, 1.65)

< 0.001

1.43 (1.35, 1.51)

< 0.001

1.34 (1.27, 1.42)

< 0.001

  1. HR Hazard Ratio, CI Confidence Interval.
  2. Model 1: Crude.
  3. Model 2: Adjust: gender, age, weight, SOFA.
  4. Model 3: Adjust: gender, age, weight, SOFA, WBC, RBC, RDW, hemoglobin, platelet, creatinine, BUN, anion gap, sodium, potassium, calcium.
  5. Model 4: Adjust: gender, age, weight, SOFA, WBC, RBC, RDW, hemoglobin, platelet, creatinine, BUN, anion gap, sodium, potassium, calcium, HR, SBP, DBP, RR, SpO2, myocardial infarction, cerebrovascular disease, diabetes, hypertension, atrial fibrillation, beta blocker, ACEI/ARB/ARNI, antidiabetics, diuretic.
Back to article page